跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PAROXETINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PAROXETINE
Authorized
STANDARD
PAROXETINE
altamed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
991be19fbd9333f9
Company
altamed pharma
Type
Standard
Approval Details
Approval Id
991be19fbd9333f9
Drug Approval Canada Name
PAROXETINE
Product Name
PAROXETINE
Status
Marketed
Status Date
2023-02-22
Original Market Date
2019-03-05
Din
02477831
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB05 PAROXETINE
Atc Name
n 06 ab 05
Aig Number
0123131002
Company Name
altamed pharma
Company Address
151 Boulevard De Mortagne, Boucherville, Quebec, Canada, J4B 6G4
Active Ingredients
PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE)
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
991be19fbd9333f9
Type
Standard
Back to Health Canada Approvals